Results 211 to 220 of about 7,612 (306)

Evaluation of aneurysm flow divertor (stent) treatment using multi-angled 1000 fps High-Speed Angiography (HSA) and Optical Flow (OF). [PDF]

Proc SPIE Int Soc Opt Eng
Vanderbilt EA, White R, Nagesh SVS, Chivukula VK, Bednarek DR, Ionita CN, Rudin S.   +6 more
europepmc   +1 more source

Dynamic Characteristics Simulation for a Simplex Swirl Injector

Journal of the Korean Society for Aeronautical & Space Sciences, 2006
openaire   +2 more sources

A Microbial Lipid‐ATP Synthase Axis Fuels NK Cell Antitumor Activity

Advanced Science, EarlyView.
This study focuses on the mechanism by which gut microbiota‐derived outer membrane vesicles (OMVs) regulate NK cell antitumor activity. B. intestinalis is identified to decrease extra‐intestinal tumor growth via its OMVs enriched in sphingosine (SP).
Kaiyuan Yu, Xinyu Sun, Wanxia Ma, Jianming Yang, Xuan Sun, Lisong Zhang, Yumeng Liu, Tianshu Ren, Qi Wang, Jingyu Wang, Xiao Li, Xianping Peng, Liu Yang, Junqiang Lv, Zhi Yao, Zhi‐Song Zhang, Quan Wang   +16 more
wiley   +1 more source

Demonstration of 1000 fps High-Speed Angiography (HSA) in Pre-Clinical In-vivo Rabbit Aneurysm Models During Flow-Diverter Treatment. [PDF]

Proc SPIE Int Soc Opt Eng
Vanderbilt EA, Koenighsknecht C, Pionessa D, Ionita CN, Bednarek DR, Rudin S, Setlur Nagesh SV.   +6 more
europepmc   +1 more source

RENAL‐CHIP: Rejection Evaluation via Non‐Invasive Analysis of Circulating Podocytes With Herringbone‐Chip Isolation Platform

Advanced Science, EarlyView.
RENAL‐CHIP converts 1 mL of peripheral blood into a biopsy‐equivalent readout of renal‐allograft fate. By magnetic capture and release of donor‐derived circulating podocytes through a herringbone microfluidic chip, 84% capture, 96% release and single‐cell RNA evidence of rejection‐specific immunity are achieved.
Juan Song, Yilong Liu, Zeyuan Zheng, Ming Zhu, Yuning Zou, Pei Liu, Yue Zheng, Xiyuan Yu, Jianzhong Zheng, Chen Shao, Huimin Zhang, Chaoyong Yang   +11 more
wiley   +1 more source

Numerical investigation of the effects of hydrogen/ammonia addition to n-heptane combustion and emissions for a dual injection compression-ignition engine. [PDF]

Heliyon
Ghadamkheir K, Safamanesh F, Moghiman M, Hatami M.   +3 more
europepmc   +1 more source

An Implantable Scaffold Sequentially Releasing STING Agonist and B7‐H3 Antibody for Bone Metastasis Immunotherapy

Advanced Science, EarlyView.
We developed an implantable dual‐drug depot using GelMA for bone metastasis treatment, co‐delivering MSA‐2 and αB7‐H3‐loaded CaCO3 microparticles. Sustained release from GelMA scaffold enables MSA‐2 to activate STING signaling and enhance T‐cell infiltration and activation, while sequentially released αB7‐H3 blocks MSA‐2‐induced B7‐H3 upregulation ...
Qijun Lin, Hong Xiao, Shuai Fan, Kaimin Cai, Yanteng Xu, Xinwen Wang, Guanhong Chen, Chuandong Lang, Xinsheng Peng, Mingqiang Li, Yuhu Dai   +10 more
wiley   +1 more source

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice. [PDF]

J Vis Exp
Li H, Walker M, Ji H, Sikirzhytskaya A, Aksenova M, Shtutman M, Sikirzhytski V, Mactutus CF, Booze RM.   +8 more
europepmc   +1 more source

Tailored Porous Bimetallic Nanozyme Platform for Full‐Cycle Therapeutics of Intestinal Ischemia/Reperfusion

Advanced Science, EarlyView.
ABSTRACT Intestinal ischemia/reperfusion (I/R) injury presents a biphasic pathology: an acute oxidative‐inflammatory phase leading to organ failure, and a recovery phase marked by mucosal dysfunction and bacterial translocation. The developed MPB@TA‐Cu‐Ma nanocomposite functions as a dual‐phase therapeutic platform with significant efficacy. It rapidly
Chenghao Qiu, Wenjing Xian, Mengxue Wang, Guozhi Zhao, Yanhuo Zhang, Zhiyu Zhou, Bo Sheng, Zhuo Zhen, Xie Liu, Shouwen Diao, Mengwei Tu, Chen Qiu, Huixian Wang, Jianbo Zhang, Peng Zhu, Tong Li   +15 more
wiley   +1 more source

Experimental investigation of diffusion flames with different baffle-plate air-hole diameters. [PDF]

Sci Rep
Mohammed ES, Gad HM, Ibrahim IA, Habik SE, Elsakka MM.   +4 more
europepmc   +1 more source